menu
    • menu

    Company profile for Orbis Biosciences

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orbis Biosciences has a diverse product portfolio to leverage where Precision Particle Fabrication® technology differentiates products. We are focused on creating novel oral and injectable therapeutics to improve compliance and patient satisfaction. Our products address clinical needs and are at various stages of development. Many of the products are based on strategic partnerships with pharmaceutical companies. Products d...
    Orbis Biosciences has a diverse product portfolio to leverage where Precision Particle Fabrication® technology differentiates products. We are focused on creating novel oral and injectable therapeutics to improve compliance and patient satisfaction. Our products address clinical needs and are at various stages of development. Many of the products are based on strategic partnerships with pharmaceutical companies. Products developed internally are positioned for co-development and licensing arrangements.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orbis BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8006 Reeder Street Lenexa, KS 66214
    Telephone
    Telephone
    +1 913-544-1199
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://orbisbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orbis-biosciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OrbisBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Santen, Orbis to tackle increasing burden of eye diseases in Asia
    Santen, Orbis to tackle increasing burden of eye diseases in Asia

    09 Oct 2020

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/30/16882/santen-orbis-to-tackle-increasing-burden-of-eye-diseases-in-asia.html

    BIOSPECTRUMASIA
    09 Oct 2020
    Share Share
    Santen and Orbis International Announce Long-term Partnership
    Santen and Orbis International Announce Long-term Partnership

    07 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/santen-and-orbis-international-announce-long-term-partnership-to-tackle-the-increasing-burden-of-eye-diseases-301148056.html

    PRNEWSWIRE
    07 Oct 2020
    Share Share
    New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis
    New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis

    02 Jun 2020

    // PRNASIA

    https://en.prnasia.com/releases/global/new-small-cell-lung-cancer-drug-accepted-for-tga-evaluation-under-project-orbis-281703.shtml

    PRNASIA
    02 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search